1. Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 2017;24:C5-8.
[CROSSREF] [PUBMED]
2. Ho KK, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, et al. The tale in evolution: clarity, consistency and consultation, not contradiction and confusion. Pituitary 2020;23:476-7.
[CROSSREF] [PUBMED]
3. Ho KK, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, et al. A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 2019;22:569-73.
[PUBMED]
4. Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A, et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 2020;37:123-34.
[CROSSREF] [PUBMED]
5. Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevigne A, et al. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of GS and Gq/11. Nat Commun 2020;11:4752.
[CROSSREF] [PUBMED] [PMC]
6. Li C, Xie W, Rosenblum JS, Zhou J, Guo J, Miao Y, et al. Somatic SF3B1 hotspot mutation in prolactinomas. Nat Commun 2020;11:2506.
[CROSSREF] [PUBMED] [PMC]
7. Fleseriu M, Pivonello R, Elenkova A, Salvatori R, Auchus RJ, Feelders RA, et al. Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing’s syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial. Lancet Diabetes Endocrinol 2019;7:855-65.
[CROSSREF] [PUBMED]
8. Pivonello R, Fleseriu M, Newell-Price J, Bertagna X, Findling J, Shimatsu A, et al. Efficacy and safety of osilodrostat in patients with Cushing’s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol 2020;8:748-61.
[CROSSREF] [PUBMED]
9. Lee JM, Kim MK, Ko SH, Koh JM, Kim BY, Kim SW, et al. Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab (Seoul) 2017;32:200-18.
[CROSSREF] [PUBMED] [PMC]
10. Ebbehoj A, Li D, Kaur RJ, Zhang C, Singh S, Li T, et al. Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. Lancet Diabetes Endocrinol 2020;8:894-902.
[CROSSREF] [PUBMED]
11. Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med 2020;173:10-20.
[PUBMED] [PMC]
13. Bancos I, Taylor AE, Chortis V, Sitch AJ, Jenkinson C, Davidge-Pitts CJ, et al. Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study. Lancet Diabetes Endocrinol 2020;8:773-81.
14. Constantinescu G, Langton K, Conrad C, Amar L, Assie G, Gimenez-Roqueplo AP, et al. Glucocorticoid excess in patients with pheochromocytoma compared with paraganglioma and other forms of hypertension. J Clin Endocrinol Metab 2020;105:e3374-83.
[CROSSREF] [PMC]
15. Burrello J, Burrello A, Pieroni J, Sconfienza E, Forestiero V, Rabbia P, et al. Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism. J Clin Endocrinol Metab 2020;105:dgaa379.
[CROSSREF] [PUBMED]
16. Burrello J, Burrello A, Pieroni J, Sconfienza E, Forestiero V, Amongero M, et al. Prediction of hyperaldosteronism subtypes when adrenal vein sampling is unilaterally successful. Eur J Endocrinol 2020;183:657-67.
[CROSSREF] [PUBMED]
17. Morisaki M, Kurihara I, Itoh H, Naruse M, Takeda Y, Katabami T, et al. Predictors of clinical success after surgery for primary aldosteronism in the Japanese nationwide cohort. J Endocr Soc 2019;3:2012-22.
[CROSSREF] [PUBMED] [PMC]
18. Williams TA, Lenders JW, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017;5:689-99.
[CROSSREF]
19. Burrello J, Burrello A, Stowasser M, Nishikawa T, Quinkler M, Prejbisz A, et al. The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism. Ann Surg 2020;272:1125-32.
[CROSSREF]